Launch of Applications for the AbbVie Japan Innovation Award in Partnership with BioLabs

June 15, 2026
 

AbbVie Japan (headquartered in Minato-ku, Tokyo; President: Tiago Campos Rodrigues) announced today that applications are now open for the AbbVie Japan Innovation Award launched in partnership with BioLabs. Now in its second year, the award is designed to support the development of Japan’s life sciences innovation ecosystem.

Applications are now open to promising bio startups and academic institutions advancing scientific research and development of technologies with the potential to create innovative therapies across  AbbVie’s key therapeutic areas: immunology, oncology, neuroscience, obesity, and aesthetics. Special consideration will be given to companies focused on genetic medicine, biologics, pain, migraine, neuropsychiatry, obesity/metabolism, and respiratory.　

The award comprises two components: the BioLabs Golden Ticket Program, providing one year of complimentary space at BioLabs Tokyo, where AbbVie is a founding sponsor, and the AbbVie Special Mentoring Program, offering one year of mentorship from AbbVie R&D experts.

For more information on how to apply, please visit: biolabs.io/abbviejapaninnovationaward.